Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
Authors
Keywords
Malaria, Pfs25, <em class=EmphasisTypeItalic >Plasmodium falciparum</em>, Transmission blocking vaccine, Baculovirus, <em class=EmphasisTypeItalic >Pichia</em>, Glycosylation, Recombinant protein
Journal
MALARIA JOURNAL
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-08-11
DOI
10.1186/s12936-016-1464-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Method for Producing Protein Nanoparticles with Applications in Vaccines
- (2016) David S. Jones et al. PLoS One
- Evaluation of the Impact of Codon Optimization and N-Linked Glycosylation on Functional Immunogenicity of Pfs25 DNA Vaccines Delivered byIn VivoElectroporation in Preclinical Studies in Mice
- (2015) Dibyadyuti Datta et al. Clinical and Vaccine Immunology
- Building an effective malaria vaccine pipeline to address global needs
- (2015) Ashley J. Birkett VACCINE
- Recent advances in recombinant protein-based malaria vaccines
- (2015) Simon J. Draper et al. VACCINE
- Potent Malaria Transmission-Blocking Antibody Responses Elicited by Plasmodium falciparum Pfs25 Expressed in Escherichia coli after Successful Protein Refolding
- (2014) Rajesh Kumar et al. INFECTION AND IMMUNITY
- Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward
- (2014) Julia K. Nunes et al. VACCINE
- Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays
- (2013) Kazutoyo Miura et al. PLoS One
- In silico Platform for Prediction of N-, O- and C-Glycosites in Eukaryotic Protein Sequences
- (2013) Jagat Singh Chauhan et al. PLoS One
- A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice
- (2013) R. Mark Jones et al. PLoS One
- Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities
- (2013) Ashley J. Birkett et al. VACCINE
- Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle
- (2013) Richard L. Shimp et al. VACCINE
- Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission
- (2012) James A. Gregory et al. PLoS One
- Antibodies to plant-producedPlasmodium falciparumsexual stage protein Pfs25 exhibit transmission blocking activity
- (2011) Christine E. Farrance et al. Human vaccines & immunotherapeutics
- SignalP 4.0: discriminating signal peptides from transmembrane regions
- (2011) Thomas Nordahl Petersen et al. NATURE METHODS
- An improved method for the in vitro differentiation of Plasmodium falciparum gametocytes into ookinetes
- (2010) Anil K Ghosh et al. MALARIA JOURNAL
- The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species
- (2010) Lediya Cheru et al. VACCINE
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started